UnknownPhase 2NCT03465111
A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis
Studying Infectious scleritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Metropolitan Eye Research & Surgery Institute
- Principal Investigator
- David S. Chu, MDMetropolitan Eye Research and Surgery Institute
- Intervention
- ACTH (adrenocorticotropic hormone) gel(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2024
Study locations (3)
- Byers Eye Institute, Stanford University, Palo Alto, California, United States
- Metropolitan Eye Research and Surgery Institute, Palisades Park, New Jersey, United States
- Foresight Studies, LLC, San Antonio, Texas, United States
Collaborators
Mallinckrodt · Stanford University · Ocular Imaging Research and Reading Center · Foresight Studies, LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03465111 on ClinicalTrials.gov